Does the media refer more to HNGE or PRVA?

In the previous week, Hinge Health had 7 more articles in the media than Privia Health Group. MarketBeat recorded 11 mentions for Hinge Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Hinge Health's score of 0.51 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 5 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PRVA or HIMS?

In the previous week, Hims & Hers Health had 26 more articles in the media than Privia Health Group. MarketBeat recorded 30 mentions for Hims & Hers Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Hims & Hers Health's score of 0.18 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 3 Very Positive mention(s) 3 Positive mention(s) 24 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, CHE or PRVA?

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.53B 2.58 $265.24M $19.91 25.07 Privia Health Group $2.12B 1.25 $22.92M $0.21 99.29

Does the media prefer CHE or PRVA?

In the previous week, Chemed had 2 more articles in the media than Privia Health Group. MarketBeat recorded 6 mentions for Chemed and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Chemed's score of 0.19 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PRVA or RDNT?

In the previous week, Privia Health Group had 1 more articles in the media than RadNet. MarketBeat recorded 4 mentions for Privia Health Group and 3 mentions for RadNet. RadNet's average media sentiment score of 0.66 beat Privia Health Group's score of 0.52 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PRVA or BLLN?

In the previous week, Billiontoone had 9 more articles in the media than Privia Health Group. MarketBeat recorded 13 mentions for Billiontoone and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Billiontoone's score of 0.24 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Privia Health Group (PRVA) Competitors

$20.85 +0.66 (+3.27%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$20.84 -0.01 (-0.02%)

As of 10/9/2026 07:30 PM Eastern

Compare

PRVA vs. HNGE, HIMS, CHE, RDNT, and BLLN

Should you buy Privia Health Group stock or one of its competitors? Privia Health Group's main competitors and comparable companies include Hinge Health (HNGE), Hims & Hers Health (HIMS), Chemed (CHE), RadNet (RDNT), and Billiontoone (BLLN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Privia Health Group compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Privia Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	14.11	-$528.26M	$1.28	80.33
Privia Health Group	$2.12B	1.25	$22.92M	$0.21	99.29

Hinge Health has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

In the previous week, Hinge Health had 7 more articles in the media than Privia Health Group. MarketBeat recorded 11 mentions for Hinge Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Hinge Health's score of 0.51 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health currently has a consensus target price of $105.33, suggesting a potential upside of 2.44%. Privia Health Group has a consensus target price of $31.00, suggesting a potential upside of 48.68%. Given Privia Health Group's higher possible upside, analysts clearly believe Privia Health Group is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

94.5% of Privia Health Group shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hinge Health has a net margin of 15.15% compared to Privia Health Group's net margin of 1.19%. Hinge Health's return on equity of 51.60% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Privia Health Group	1.19%	3.52%	2.00%

Summary

Hinge Health beats Privia Health Group on 11 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

Privia Health Group has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.44, indicating that its share price is 144% more volatile than the broader market.

94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Privia Health Group presently has a consensus price target of $31.00, suggesting a potential upside of 48.68%. Hims & Hers Health has a consensus price target of $32.43, suggesting a potential upside of 5.08%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

Privia Health Group has a net margin of 1.19% compared to Hims & Hers Health's net margin of -5.51%. Privia Health Group's return on equity of 3.52% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.25	$22.92M	$0.21	99.29
Hims & Hers Health	$2.35B	3.07	$128.37M	-$0.63	N/A

In the previous week, Hims & Hers Health had 26 more articles in the media than Privia Health Group. MarketBeat recorded 30 mentions for Hims & Hers Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Hims & Hers Health's score of 0.18 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	3 Very Positive mention(s)	3 Positive mention(s)	24 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Privia Health Group beats Hims & Hers Health on 10 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Chemed?

Chemed (NYSE:CHE) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Chemed has a net margin of 10.60% compared to Privia Health Group's net margin of 1.19%. Chemed's return on equity of 31.77% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Privia Health Group	1.19%	3.52%	2.00%

Chemed presently has a consensus target price of $554.60, indicating a potential upside of 11.11%. Privia Health Group has a consensus target price of $31.00, indicating a potential upside of 48.68%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts plainly believe Privia Health Group is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

In the previous week, Chemed had 2 more articles in the media than Privia Health Group. MarketBeat recorded 6 mentions for Chemed and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Chemed's score of 0.19 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	0 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.9% of Chemed shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 3.3% of Chemed shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.58	$265.24M	$19.91	25.07
Privia Health Group	$2.12B	1.25	$22.92M	$0.21	99.29

Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Summary

Chemed beats Privia Health Group on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to RadNet?

Privia Health Group (NASDAQ:PRVA) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

Privia Health Group presently has a consensus price target of $31.00, indicating a potential upside of 48.68%. RadNet has a consensus price target of $90.00, indicating a potential upside of 26.92%. Given Privia Health Group's higher probable upside, research analysts clearly believe Privia Health Group is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

Privia Health Group has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

In the previous week, Privia Health Group had 1 more articles in the media than RadNet. MarketBeat recorded 4 mentions for Privia Health Group and 3 mentions for RadNet. RadNet's average media sentiment score of 0.66 beat Privia Health Group's score of 0.52 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Privia Health Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.25	$22.92M	$0.21	99.29
RadNet	$2.04B	2.74	-$18.65M	-$0.27	N/A

94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 5.7% of Privia Health Group shares are held by insiders. Comparatively, 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Privia Health Group has a net margin of 1.19% compared to RadNet's net margin of -0.93%. Privia Health Group's return on equity of 3.52% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
RadNet	-0.93%	2.61%	0.91%

Summary

Privia Health Group beats RadNet on 12 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Billiontoone?

Privia Health Group (NASDAQ:PRVA) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

Privia Health Group presently has a consensus target price of $31.00, suggesting a potential upside of 48.68%. Billiontoone has a consensus target price of $126.25, suggesting a potential upside of 28.71%. Given Privia Health Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Privia Health Group is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55

In the previous week, Billiontoone had 9 more articles in the media than Privia Health Group. MarketBeat recorded 13 mentions for Billiontoone and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.52 beat Billiontoone's score of 0.24 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Billiontoone has a net margin of 8.04% compared to Privia Health Group's net margin of 1.19%. Billiontoone's return on equity of 9.96% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Billiontoone	8.04%	9.96%	5.35%

94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by insiders. Comparatively, 50.2% of Billiontoone shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Privia Health Group has higher revenue and earnings than Billiontoone. Privia Health Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.25	$22.92M	$0.21	99.29
Billiontoone	$305.11M	15.17	$7.45M	$0.70	140.13

Summary

Billiontoone beats Privia Health Group on 8 of the 15 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRVA vs. The Competition

Export

Metric	Privia Health Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.66B	$9.94B	$7.25B	$13.30B
Dividend Yield	N/A	2.61%	2.52%	22.58%
P/E Ratio	99.29	34.10	275.01	26.14
Price / Sales	1.25	4.83	582.85	87.88
Price / Cash	78.13	114.01	76.96	53.71
Price / Book	3.24	5.11	11.22	6.33
Net Income	$22.92M	$315.68M	$3.50B	$382.15M
7 Day Performance	2.71%	-0.38%	-0.89%	-1.40%
1 Month Performance	2.11%	-2.14%	-4.02%	-3.35%
1 Year Performance	-13.41%	12.73%	7.13%	1.49%

Privia Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRVA Privia Health Group	3.7012 of 5 stars	$20.85 +3.3%	$31.00 +48.7%	-13.4%	$2.66B	$2.12B	99.29	1,226
HNGE Hinge Health	2.4294 of 5 stars	$97.90 -0.5%	$105.33 +7.6%	+107.0%	$7.90B	$720.06M	76.46	1,437	Analyst Downgrade Insider Trade
HIMS Hims & Hers Health	1.6487 of 5 stars	$29.31 -1.2%	$32.43 +10.7%	-42.8%	$6.83B	$2.58B	N/A	2,442	Trending News Gap Up
CHE Chemed	4.422 of 5 stars	$509.19 -0.4%	$554.60 +8.9%	+16.3%	$6.66B	$2.53B	25.60	15,811	News Coverage Analyst Upgrade
RDNT RadNet	3.4715 of 5 stars	$70.07 -0.7%	$90.00 +28.4%	+0.4%	$5.51B	$2.04B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRVA) was last updated on 10/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Competitors

PRVA vs. HNGE, HIMS, CHE, RDNT, and BLLN

How does Privia Health Group compare to Hinge Health?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Summary

How does Privia Health Group compare to Chemed?

Summary

How does Privia Health Group compare to RadNet?

Summary

How does Privia Health Group compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Competitors

PRVA vs. HNGE, HIMS, CHE, RDNT, and BLLN

How does Privia Health Group compare to Hinge Health?

Which has higher valuation and earnings, HNGE or PRVA?

Which has more risk and volatility, HNGE or PRVA?

Does the media refer more to HNGE or PRVA?

Do analysts recommend HNGE or PRVA?

Do insiders and institutionals have more ownership in HNGE or PRVA?

Is HNGE or PRVA more profitable?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Which has more volatility and risk, PRVA or HIMS?

Do insiders & institutionals have more ownership in PRVA or HIMS?

Do analysts recommend PRVA or HIMS?

Is PRVA or HIMS more profitable?

Which has preferable earnings & valuation, PRVA or HIMS?

Does the media refer more to PRVA or HIMS?

Summary

How does Privia Health Group compare to Chemed?

Is CHE or PRVA more profitable?

Do analysts rate CHE or PRVA?

Does the media prefer CHE or PRVA?

Do insiders & institutionals believe in CHE or PRVA?

Which has preferable valuation and earnings, CHE or PRVA?

Which has more volatility & risk, CHE or PRVA?

Summary

How does Privia Health Group compare to RadNet?

Do analysts rate PRVA or RDNT?

Which has more volatility & risk, PRVA or RDNT?

Does the media prefer PRVA or RDNT?

Which has better earnings and valuation, PRVA or RDNT?

Do institutionals and insiders hold more shares of PRVA or RDNT?

Is PRVA or RDNT more profitable?

Summary

How does Privia Health Group compare to Billiontoone?

Do analysts prefer PRVA or BLLN?

Does the media prefer PRVA or BLLN?

Is PRVA or BLLN more profitable?

Do insiders and institutionals have more ownership in PRVA or BLLN?

Which has higher valuation & earnings, PRVA or BLLN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools